These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

581 related items for PubMed ID: 24751563

  • 1. Management of hypertrophic cardiomyopathy.
    Enriquez AD, Goldman ME.
    Ann Glob Health; 2014; 80(1):35-45. PubMed ID: 24751563
    [Abstract] [Full Text] [Related]

  • 2. Long-term outcomes after medical and invasive treatment in patients with hypertrophic cardiomyopathy.
    Vriesendorp PA, Liebregts M, Steggerda RC, Schinkel AF, Willems R, Ten Cate FJ, van Cleemput J, Ten Berg JM, Michels M.
    JACC Heart Fail; 2014 Dec; 2(6):630-6. PubMed ID: 25447346
    [Abstract] [Full Text] [Related]

  • 3. The development of familial hypertrophic cardiomyopathy: from mutation to bedside.
    Brouwer WP, van Dijk SJ, Stienen GJ, van Rossum AC, van der Velden J, Germans T.
    Eur J Clin Invest; 2011 May; 41(5):568-78. PubMed ID: 21158848
    [Abstract] [Full Text] [Related]

  • 4. [Therapy and risk-stratification in hypertrophic cardiomyopathy--a current survey].
    Reith S, Klues HG.
    Z Kardiol; 2003 Apr; 92(4):283-93. PubMed ID: 12707787
    [Abstract] [Full Text] [Related]

  • 5. Surgical septal myectomy decreases the risk for appropriate implantable cardioverter defibrillator discharge in obstructive hypertrophic cardiomyopathy.
    McLeod CJ, Ommen SR, Ackerman MJ, Weivoda PL, Shen WK, Dearani JA, Schaff HV, Tajik AJ, Gersh BJ.
    Eur Heart J; 2007 Nov; 28(21):2583-8. PubMed ID: 17483110
    [Abstract] [Full Text] [Related]

  • 6. Clinical Outcomes in Patients With Nonobstructive, Labile, and Obstructive Hypertrophic Cardiomyopathy.
    Lu DY, Pozios I, Haileselassie B, Ventoulis I, Liu H, Sorensen LL, Canepa M, Phillip S, Abraham MR, Abraham TP.
    J Am Heart Assoc; 2018 Feb 25; 7(5):. PubMed ID: 29478967
    [Abstract] [Full Text] [Related]

  • 7. [Hypertrophic cardiomyopathy in 2013].
    Giannakopoulos G, Frangos C.
    Rev Med Suisse; 2013 Mar 06; 9(376):502, 504-7. PubMed ID: 23534110
    [Abstract] [Full Text] [Related]

  • 8. Fragmented QRS predicts heart failure progression in patients with hypertrophic cardiomyopathy.
    Nomura A, Konno T, Fujita T, Tanaka Y, Nagata Y, Tsuda T, Hodatsu A, Sakata K, Nakamura H, Kawashiri MA, Fujino N, Yamagishi M, Hayashi K.
    Circ J; 2015 Mar 06; 79(1):136-43. PubMed ID: 25381793
    [Abstract] [Full Text] [Related]

  • 9. Current perspectives in hypertrophic cardiomyopathy with the focus on patients in the Finnish population: a review.
    Kuusisto J, Sipola P, Jääskeläinen P, Naukkarinen A.
    Ann Med; 2016 Nov 06; 48(7):496-508. PubMed ID: 27460395
    [Abstract] [Full Text] [Related]

  • 10. Hypertrophic cardiomyopathy.
    Maron BJ, Maron MS.
    Lancet; 2013 Jan 19; 381(9862):242-55. PubMed ID: 22874472
    [Abstract] [Full Text] [Related]

  • 11. [Management of hypertrophic cardiomyopathy - the most common inherited heart disease].
    Magnusson P, Gadler F, Mörner S.
    Lakartidningen; 2018 Jun 11; 115():. PubMed ID: 29893985
    [Abstract] [Full Text] [Related]

  • 12. Implantable cardioverter defibrillator therapy and sudden death risk stratification in hypertrophic cardiomyopathy patients with midventricular obstruction: A single-center experience.
    Maeda R, Minami Y, Haruki S, Kanbayashi K, Itani R, Suzuki A, Ejima K, Shiga T, Shoda M, Hagiwara N.
    Int J Cardiol; 2016 Jul 01; 214():419-22. PubMed ID: 27088403
    [Abstract] [Full Text] [Related]

  • 13. Review on sudden death risk reduction after septal reduction therapies in hypertrophic obstructive cardiomyopathy.
    Rigopoulos AG, Ali M, Abate E, Matiakis M, Melnyk H, Mavrogeni S, Leftheriotis D, Bigalke B, Noutsias M.
    Heart Fail Rev; 2019 May 01; 24(3):359-366. PubMed ID: 30617667
    [Abstract] [Full Text] [Related]

  • 14. [Alcohol septal ablation and prevention of sudden cardiac death in patients with hypertrophic cardiomyopathy. A case report].
    Ardashev AV, Shavarov AA, Dzhandzhgava AO, Rybachenko MS, Kriuchko MIu.
    Kardiologiia; 2009 May 01; 49(6):72-9. PubMed ID: 19656099
    [Abstract] [Full Text] [Related]

  • 15. Prevention of sudden death in hypertrophic cardiomyopathy: bridging the gaps in knowledge.
    Weissler-Snir A, Adler A, Williams L, Gruner C, Rakowski H.
    Eur Heart J; 2017 Jun 07; 38(22):1728-1737. PubMed ID: 27371714
    [Abstract] [Full Text] [Related]

  • 16. Hypertrophic cardiomyopathy: present and future, with translation into contemporary cardiovascular medicine.
    Maron BJ, Ommen SR, Semsarian C, Spirito P, Olivotto I, Maron MS.
    J Am Coll Cardiol; 2014 Jul 08; 64(1):83-99. PubMed ID: 24998133
    [Abstract] [Full Text] [Related]

  • 17. [Sudden cardiac death in familial hypertrophic cardiomyopathy. Identification of high-risk patients].
    Pellnitz C, Geier C, Perrot A, Dietz R, Osterziel KJ, Haverkamp W.
    Dtsch Med Wochenschr; 2005 May 06; 130(18):1150-4. PubMed ID: 15856398
    [Abstract] [Full Text] [Related]

  • 18. [Interventional treatment in hypertrophic cardiomyopathy].
    Gietzen FH, Schümmelfeder J, Neuser H, Brunn J, Schumacher B, Kerber S.
    Herz; 2005 Mar 06; 30(2):102-10. PubMed ID: 15875098
    [Abstract] [Full Text] [Related]

  • 19. [Prevention of sudden death in hypertrophic cardiomyopathy (HCM ): implanted defibrillators in HCM].
    Maron BJ, Spirito P.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Apr 06; 37(4):297-302. PubMed ID: 19791462
    [Abstract] [Full Text] [Related]

  • 20. Recent progress in end-stage hypertrophic cardiomyopathy.
    Xiao Y, Yang KQ, Jiang Y, Zhou XL.
    Am J Med Sci; 2015 May 06; 349(5):448-53. PubMed ID: 25901536
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.